Antibodies armed with photosensitizers: from chemical synthesis to photobiological applications
- 6 January 2015
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 13 (9) , 2518-2529
Abstract
Targeting photosensitizers to cancer cells by conjugating them with specific antibodies, able to recognize and bind to tumor-associated antigens, is today one of the most attractive strategies in photodynamic therapy (PDT). This comprehensive review updates on chemical routes available for the preparation of photo-immunoconjugates (PICs), which show dual chemical and biological functionalities: photo-properties of the photosensitizer and the immunoreactivity of the antibody. Moreover, photobiological results obtained with such photo-immunoconjugates using in vitro and in vivo cancer models are also discussed.Keywords
This publication has 79 references indexed in Scilit:
- Antibody-Directed Phototherapy (ADP)Antibodies, 2013
- Near-infrared Theranostic Photoimmunotherapy (PIT): Repeated Exposure of Light Enhances the Effect of ImmunoconjugateBioconjugate Chemistry, 2012
- Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane moleculesNature Medicine, 2011
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vesselsBritish Journal of Cancer, 2011
- Mono- and tri-cationic porphyrin-monoclonal antibody conjugates: photodynamic activity and mechanism of actionImmunology, 2010
- Photodynamic therapy: novel third‐generation photosensitizers one step closer?British Journal of Pharmacology, 2008
- Development and characterization of novel photosensitizer : scFv conjugates for use in photodynamic therapy of cancerImmunology, 2007
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Photodynamic therapy of squamous cell carcinoma. An evaluation of a new photosensitizing agent, benzoporphyrin derivative and new photoimmunoconjugateSurgical Oncology, 1993